A lawsuit filed in mid-July seeks compensation and damages for 18 patients who claim that Merck’s anti-shingles vaccine Zostavax actually gave them the condition they were seeking to avoid. Hailing from a variety of states, the plaintiffs have come together to sue Merck in its home state of New Jersey.
Zostavax is targeted at people aged 50 years or older and the CDC has gone so far as to ...
continue reading...
Up to 360 employees of Merck’s 7,400 New Jersey employees could either lose their jobs or see their positions relocated as the company shifts efforts toward exploratory biology.
The cuts will come from the company’s pre-clinical, discovery, and early development group. Citing a need to break into emerging research arenas, the change in strategy will result in staffing level changes in Kenilworth and Rahway, New Jersey as well as North Wales, ...
continue reading...
